The M4PM tumours, organoids and spheroids in space will be grown in a low shear environment to more heterogeneously sized high-quality 3D constructs which can be used for in-Space drug screening, drug optimisation, disease modelling and personalized medicine (e.g. cancer treatments) either for industrial pre-clinical testing or academic research purposes.